Adagen (Sigma-Tau Pharmaceuticals, Inc.)


Welcome to the PulseAid listing for the Adagen drug offered from Sigma-Tau Pharmaceuticals, Inc.. This Adenosine Deaminase [Chemical/Ingredient],Bovine Intestinal Adenosine Deaminase [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Sigma-Tau Pharmaceuticals, Inc.
NON-PROPRIETARY NAME: pegademase bovine
SUBSTANCE NAME: PEGADEMASE BOVINE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Adenosine Deaminase [Chemical/Ingredient],Bovine Intestinal Adenosine Deaminase [EPC]
ROUTE: INTRAMUSCULAR
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2010-10-18
END MARKETING DATE: 0000-00-00


Adagen HUMAN PRESCRIPTION DRUG Details:

Item DescriptionAdagen from Sigma-Tau Pharmaceuticals, Inc.
LABELER NAME: Sigma-Tau Pharmaceuticals, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 250([iU]/mL)
START MARKETING DATE: 2010-10-18
END MARKETING DATE: 0000-00-00
PRODUCT ID: 57665-001_c3234ac4-a1a4-4450-99cc-627a295e20ae
PRODUCT NDC: 57665-001
APPLICATION NUMBER: NDA019818

Other PEGADEMASE BOVINE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Sigma-Tau Pharmaceuticals, Inc.Adagen